Continuing Education
You are invited to participate in this continuing medical education program which includes:
- Patient Case Log Continuing Education Program
- LINK Nurse Program: Maintaining Your Bone Health During and After Cancer Treatment
Register Below
Cancer and cancer treatments can adversely affect bone health, resulting in bone loss, bone metastases, and skeletal-related complications. This is particularly true for patients with breast cancer, prostate cancer, and multiple myeloma. Increasing evidence demonstrates that the administration of hormonal therapies, including aromatase inhibitors for the treatment of breast cancer, contributes to a decrease in bone mineral density with a subsequent increased risk for fracture and related comorbidities.
Because skeletal complications and associated comorbidities have a significant impact on patient health and quality of life, it is important for healthcare professionals involved in the care of cancer patients to understand that skeletal complications can be prevented, in part, by identifying patients at risk for bone loss and/or bone metastases and implementing preventive measures to reduce these risks.